Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes-Reference-Cited by-同舟云学术

Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes

Published:2017-01-11 Issue:2 Volume:16 Page:157-166
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Sun Hengrui¹,Kawaguchi Atsushi²,Koch Gary¹

Affiliation:

1. Department of Biostatistics; Gillings School of Global Public Health, University of North Carolina at Chapel Hill; Chapel Hill NC USA

2. Department of Biomedical Statistics and Bioinformatics; Kyoto University Graduate School of Medicine; Sakyo-ku Kyoto Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference19 articles.

1. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities;Pocock;Eur. Heart J.,2012

2. Stratified multivariate Mann-Whitney estimators for the comparison of two treatments with randomization based covariance adjustment;Kawaguchi;Stat. Biopharmaceut. Res.,2011

3. A. Kawaguchi G. G. Koch Sanon: an R package for stratified analysis with nonparametric covariable adjustment J. Stat. Softw. 2015 67 9 1548 7660 10.18637/jss.v067.i09

4. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them;Koch;Stat. Med.,1998

5. Randomization-based nonparametric methods for the analysis of multicentre trials;LaVange;Stat. Methods Med. Res.,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures;Journal of Biopharmaceutical Statistics;2019-12-12

2. The Win Ratio: On Interpretation and Handling of Ties;Statistics in Biopharmaceutical Research;2019-04-25

3. Commentary on “Statistics at FDA: Reflections on the Past Six Years”;Statistics in Biopharmaceutical Research;2019-01-02

4. Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on Safety;Therapeutic Innovation & Regulatory Science;2018-11